SC
ABBV icon

Sculptor Capital’s AbbVie ABBV Stock Holding History

Sculptor Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-92,900
Closed -$6.08M – 391
2014
Q4 		$6.08M Hold
92,900
– – 0.02% 434
2014
Q3 		$5.37M Buy
92,900
+45,000
+94% +$2.5M 0.02% 506
2014
Q2 		$2.7M Hold
47,900
– – 0.01% 582
2014
Q1 		$2.46M Sell
47,900
-36,700
-43% -$1.85M 0.01% 587
2013
Q4 		$4.47M Sell
84,600
-89,300
-51% -$4.39M 0.01% 570
2013
Q3 		$7.78M Sell
173,900
-32,300
-16% -$1.43M 0.02% 483
2013
Q2 		$8.52M Buy
+206,200
New +$9.02M 0.03% 443

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sculptor Capital's ABBV Position: Q2 2022 in Review

Sculptor Capital sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 392,858 shares — an estimated $63.7M sold.

Sculptor Capital first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $886M in Q3 2014. 3,006 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Sculptor Capital reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Sculptor Capital sold 392,858 AbbVie shares in Q2 2022, an estimated $63.7M.
  • Sculptor Capital first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
  • Sculptor Capital's AbbVie position peaked at $886M in Q3 2014.
  • 3,006 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Sculptor Capital's 13F filing for Q2 2022, filed 12 Aug 2022.